Jounce Therapeutics, Inc. 8-K SEC Filings

Filed On	Filing
04 May 2023	8-K: Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more
30 Mar 2023	8-K: Departure/Election of Directors or Officers; Compensation
27 Mar 2023	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +2 more
15 Mar 2023	8-K: Other Events
13 Mar 2023	8-K: Regulation FD Disclosure
23 Feb 2023	8-K: Entry into a Material Definitive Agreement; Costs Associated with Exit or Disposal Activities +3 more
20 Jan 2023	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
05 Jan 2023	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
27 Dec 2022	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
20 Dec 2022	8-K: Departure/Election of Directors or Officers; Compensation
10 Nov 2022	8-K: Results of Operations and Financial Condition
30 Aug 2022	8-K: Regulation FD Disclosure; Other Events
04 Aug 2022	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
27 Jun 2022	8-K: Submission of Matters to a Vote of Security Holders
05 May 2022	8-K: Results of Operations and Financial Condition
07 Mar 2022	8-K: Regulation FD Disclosure
02 Mar 2022	8-K: Results of Operations and Financial Condition
10 Jan 2022	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
04 Nov 2021	8-K: Entry into a Material Definitive Agreement
04 Nov 2021	8-K: Results of Operations and Financial Condition

Comments